This week in health news: Is a male birth control pill on the way?

Could a male version be far behind? Credit: Metro file
Could a male version be far behind?
Credit: Metro file

T cells seem to be fighting cancer

Location of study: U.S.
Study subjects: 59 adults and kids
Results: Almost half the adults and children with leukemia who were treated with gene therapy made from their own T-cells kicked the disease, Penn and the Children’s Hospital of Philadelphia announced on Saturday.
Significance: Using the body’s own immune system to fight back against wayward cells could mean a breakthrough in the fight against cancer.

 

Less risky male birth control pill may be in the works

Location of study: U.K./Australia
Study subjects: Mice
Results: Modifying sperm via the deletion of receptors might be the first step in producing a new male birth control pill, according to a study reported by the Proceedings of the National Academy of Sciences of the U.S. Here, the sperm never enters ejaculation fluid — it just stays in the vans deferns. Many male contraceptives tested in the past produce long-term side effects. This modification produced 100 percent infertility without adverse effects on sexual behavior or function.
Significance: Scientists say it could take another 10 years before we come up with one out of the two drugs needed for this male birth control to work (dang!).

 

Accurate diagnosis of severity of ovarian cancer via gene markers may lead to treatment that is more accurate

Location of study: U.S.
Study subjects: 800 ovarian cancer patients
Results: Ten specific genes may identify the aggressiveness of a patient’s disease, help predict survival outcomes and result in novel therapeutic strategies tailored to patients with the most adverse survival outcomes, according to researchers in the Women’s Cancer Program at Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute. The study, which was published in Clinical Cancer Research, found that if a patient’s tumor has elevated levels of these genes, doctors will be able to predict chemo-resistance and possibly pinpoint treatments that are more effective.
Significance: “The ultimate goal is to use the 10-gene biomarker panel to develop a diagnostic kit that will identify patients with the most adverse outcome and provide targeted therapeutic strategies,” says lead researcher Dong-Joo (Ellen) Cheon, PhD. Ovarian cancer is the most lethal gynecologic cancer; one reason is that it’s often diagnosed in later, more aggressive stages.

 


News
Entertainment
Sports
Lifestyle
Local

Muslim leaders welcome NYPD surveillance changes with degree…

Leaders and advocates praise the NYPD's move to shut down a unit tied to its Muslim surveillance program but say there's more left to do.

Local

PHOTOS: More than $12 million in heroin, crystal…

Authorities seized more than 44 pounds of heroin and 17 pounds of crystal meth from two stash houses this week during a Manhattan drug bust.

Local

How to donate during the blood drive at…

The Metro-North Railroad and New York Blood Center are hosting a blood drive at Grand Central Terminal Thursday.

Local

Bloomberg launches $50 million anti-gun violence effort

Former New York Mayor Michael Bloomberg plans to spend $50 million on a grassroots anti-gun violence network to challenge the National Rifle Association.

Going Out

Tasty chicken and waffles in NYC

Try some soul food goodness around the city.

Television

'Dexter' star Jennifer Carpenter moves into producing role

The actress who played the title character's sister in "Dexter" is teaming up with producer George Stelzner to adapt Erika Hayasaki's book "The Death Class:…

The Word

Wahlburgers announce North America domination

Tuesday was a huge day for Donnie Wahlberg.

Books

Becoming friends with New York City's oldest known…

"The Life and Times of Richard Musto" tells the story, through a poem, of the oldest known homeless man in New York City.

NHL

Flyers, Rangers meet in playoffs for 11th time

The Flyers and Rangers will start a new chapter in a historic rivalry.

MLB

Masahiro Tanaka dominates Cubs over eight shutout innings

Masahiro Tanaka certainly had no-hit caliber stuff Wednesday as he allowed just two bunt singles.

MLB

MLB Power Rankings: A's are baseball's best, Brewers…

MLB Power Rankings: A's are baseball's best, Brewers and Braves right behind

NFL

Jets make Chris Johnson signing official

The Jets got their big-play threat as running back Chris Johnson signed a multi-year contract with the team on Wednesday.

Tech

5 surprising facts about Google Glass

Your sex life could get more interesting.

Wellbeing

Cognitive skills begin to drop at age 24

But the news isn't all that bad.

Career

How to get a job at a startup:…

We talked to Tarek Pertew, one of the co-founders behind Uncubed, about how to get your dream job at a startup.

Parenting

The 'smartest' summer camps across the country

See a list of summer camps across the country that emphasis learning, while still being fun.